Cite
Radiotherapy with continued EGFR‐TKIs for oligoprogressive disease in EGFR‐mutated non‐small cell lung cancer: A real‐world study.
MLA
Hu, Chunhong, et al. “Radiotherapy with Continued EGFR‐TKIs for Oligoprogressive Disease in EGFR‐mutated Non‐small Cell Lung Cancer: A Real‐world Study.” Cancer Medicine, vol. 12, no. 1, Jan. 2023, pp. 266–73. EBSCOhost, https://doi.org/10.1002/cam4.4894.
APA
Hu, C., Wu, S., Deng, R., Wu, Y., Pan, Y., Shu, L., & Wu, F. (2023). Radiotherapy with continued EGFR‐TKIs for oligoprogressive disease in EGFR‐mutated non‐small cell lung cancer: A real‐world study. Cancer Medicine, 12(1), 266–273. https://doi.org/10.1002/cam4.4894
Chicago
Hu, Chunhong, Sixuan Wu, Renfang Deng, Yuanqiang Wu, Yue Pan, Long Shu, and Fang Wu. 2023. “Radiotherapy with Continued EGFR‐TKIs for Oligoprogressive Disease in EGFR‐mutated Non‐small Cell Lung Cancer: A Real‐world Study.” Cancer Medicine 12 (1): 266–73. doi:10.1002/cam4.4894.